Related Experiment Video
Updated: Feb 27, 2026
14:39
Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma
Published on: November 4, 2010
32.6K
Severe Asthma in Children.
Sima K Ramratnam1, Leonard B Bacharier2, Theresa W Guilbert3
1University of Wisconsin School of Medicine and Public Health, Madison, Wis.
Summary
Severe asthma in children presents diverse phenotypes, requiring comprehensive evaluation and multidisciplinary care. Emerging therapies target these phenotypes, but long-term outcomes for pediatric severe asthma need further research.
Area of Science:
- Pediatric Pulmonology
- Asthma Research
- Clinical Heterogeneity
Background:
- Severe asthma in children is a significant health issue with varied clinical presentations.
- Understanding the heterogeneity of pediatric severe asthma is crucial for effective management.
- Previous cluster analyses have aimed to explain this heterogeneity.
Purpose of the Study:
- To review the heterogeneity of pediatric severe asthma.
- To discuss diagnostic assessments and factors contributing to poor control.
- To highlight current and future management strategies.
Main Methods:
- Review of existing literature on pediatric severe asthma phenotypes.
- Discussion of diagnostic evaluation processes.
- Analysis of management approaches, including multidisciplinary care and phenotypic-directed therapies.
Main Results:
- Pediatric severe asthma is characterized by multiple clinical phenotypes.
- Comprehensive evaluation must exclude other diagnoses and address adherence, technique, and environmental factors.
- Multidisciplinary care and asthma education are essential.
Conclusions:
- Phenotypic-directed therapies are emerging in pediatric severe asthma management.
- Continued research is necessary to understand long-term outcomes.
- Addressing heterogeneity is key to improving treatment efficacy.
Related Concept Videos
01:24Asthma-III: Symptoms and Complications
3.4K
Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
Classification of Asthma
3.4K
01:30Asthma-IV: Diagnostic and Management
3.2K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
3.2K
01:29Asthma-I: Introduction
3.6K
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
3.6K
01:26Asthma-II: Pathophysiology and Classification
4.7K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
4.7K
01:20Asthma: Pathogenesis and Management
1.5K
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
1.5K
01:19Antiasthma Drugs: Leukotriene Modifiers
2.0K
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Leukotriene modifiers work through two distinct mechanisms:
2.0K